Evidence map›Paper›PMID 31404850›Full record

Trial reportDrug and alcohol dependence2019

Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial.

Eric L Garland, Adam W Hanley, Anna Kline, Nina A Cooperman

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 57 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 5 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03894501 nacompletednot on this map

Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment for Opioid Use and Chronic Pain Management Pilot

TypeinterventionalSponsorRutgers, The State University of New JerseyRan2019 to 2019Enrolled30ConditionsOpioid Use, Chronic PainArmsMindfulness Oriented Recovery Enhancement, Methadone program behavioral treatment as usual
NCT05588726 nawithdrawnnot on this mapstarted 2022, after this paper: background citation

Behavioral Intervention to Improve Insomnia Symptoms in Patients With Opioid Use Disorder

TypeinterventionalSponsorUniversity of PennsylvaniaRan2022 to 2023Enrolled0ConditionsOpioid Use Disorder, InsomniaArmsSleep Hygiene, Mindfulness
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 5 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Mindfulness-based interventions for substance use disorders.The Cochrane database of systematic reviews · 2021
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Effects of behavioral interventions on stress reactivity in adults with substance use disorders.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2024
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Eric L GarlandCollege of Social Work and Center on Mindfulness and Integrative Health Intervention Development, University of Utah, 395 South, 1500 East, Salt Lake City, UT 84112 USA. Electronic address: eric.garland@socwk.utah.edu.
Adam W HanleyCollege of Social Work and Center on Mindfulness and Integrative Health Intervention Development, University of Utah, 395 South, 1500 East, Salt Lake City, UT 84112 USA.
Anna KlineRutgers Robert Wood Johnson Medical School, 675 Hoes Ln W, Piscataway, NJ 08854 USA.
Nina A CoopermanRutgers Robert Wood Johnson Medical School, 675 Hoes Ln W, Piscataway, NJ 08854 USA.
Rutgers, The State University of New Jersey · USUniversity of Utah · US

Funding

Targeting Hedonic Dysregulation to Address Chronic Pain and Opioid Misuse in Primary Care.R01DA042033 · NIDA · UNIVERSITY OF UTAH · PI GARLAND, ERIC LEE · 2016 to 2020
$2.8M
Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment for Opioid Use and Chronic Pain ManagementR33AT010109 · NCCIH · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI COOPERMAN, NINA · 2019 to 2020
$1.5M
Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment for Opioid Use and Chronic Pain ManagementR21AT010109 · NCCIH · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI COOPERMAN, NINA, KLINE, ANNA · 2018 to 2018
$312k
NCCIH NIH HHS R21 AT010109NCCIH NIH HHS R33 AT010109NIDA NIH HHS R01 DA042033
6 · The paper itself

Abstract

backgroundMethadone maintenance therapy (MMT) is an efficacious form of medication assisted treatment for opioid use disorder (OUD), yet many individuals on MMT relapse. Chronic pain and deficits in positive affective response to natural rewards may result in dysphoria that fuels opioid craving and promotes relapse. As such, behavioral therapies that ameliorate chronic pain and enhance positive affect may serve as useful adjuncts to MMT. This analysis of ecological momentary assessment (EMA) data from a Stage 1 randomized clinical trial examined effects of Mindfulness-Oriented Recovery Enhancement (MORE) on opioid craving, pain, and positive affective state.

methodsParticipants with OUD and chronic pain (N = 30) were randomized to 8 weeks of MORE or treatment as usual (TAU). Across 8 weeks of treatment, participants completed up to 112 random EMA measures of craving, pain, and affect, as well as event-contingent craving ratings. Multilevel models examined the effects of MORE on craving, pain, and affect, as well as the association between positive affect and craving.

resultsEMA showed significantly greater improvements in craving, pain unpleasantness, stress, and positive affect for participants in MORE than for participants in TAU. Participants in MORE reported having nearly 1.3 times greater self-control over craving than those in TAU. Further, positive affect was associated with reduced craving, an association that was significantly stronger among participants in MORE than TAU.

conclusionMORE may be a useful non-pharmacological adjunct among individuals with OUD and chronic pain in MMT.

Indexed as

MindfulnessAdolescentAdultAffectAnalgesics, OpioidChronic PainCombined Modality TherapyCravingEcological Momentary AssessmentFemaleHumansMaleMethadoneMiddle AgedOpiate Substitution TreatmentOpioid-Related DisordersAnalgesics, OpioidMethadoneChronic painEcological momentary assessmentMedication assisted treatmentMORESavoring

Identifiers

PMID31404850
PMCPMC6939880
OpenAlexW2965466047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.